CANTHARIDIN | N212905 | VERRICA PHARMACEUTICALS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Verrica Pharmaceuticals FDA-2023-P-4510 Verrica Pharmaceuticals Inc. filed this citizen petition on October 11, 2023, requesting that the FDA remove cantharidin from the 503A Bulks List under 21 C.F.R. § 216.23, remove it from 503B Category 1 under the Interim Policy on Compounding Bulk Drug Substances Under 503B, and issue a final notice | Other | 2023-10-13 | Denied | Verrica Pharmaceuticals |
Source: Regulations.gov. FDA citizen petitions matched by application number.